Phase 2 HCC - Hepatocellular Carcinoma Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 2
Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma
HCC - Hepatocellular CarcinomaConversion Therapy
Tianjin Medical University Cancer Institute and Hospital43 enrolled1 locationNCT07560488
Recruiting
Phase 2
A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC
HCC - Hepatocellular Carcinoma
TaiRx, Inc.40 enrolled1 locationNCT07521852
Recruiting
Phase 2
Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma
HCC - Hepatocellular Carcinoma
Zhejiang Hisun Pharmaceutical Co. Ltd.75 enrolled1 locationNCT07310173
Recruiting
Phase 2Phase 3
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
HCC - Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital20 enrolled1 locationNCT07285850
Recruiting
Phase 2
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital300 enrolled1 locationNCT07157969
Recruiting
Phase 2
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
HCC - Hepatocellular CarcinomaDurvalumabTremelimumab+1 more
Chang Gung Memorial Hospital45 enrolled1 locationNCT06999694
Recruiting
Phase 2
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill48 enrolled7 locationsNCT05690048
Recruiting
Phase 2
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
RadiotherapyHCC - Hepatocellular CarcinomaDurvalumab+1 more
Chang Gung Memorial Hospital45 enrolled1 locationNCT06999707
Recruiting
Phase 2
FGF19 Overexpression Combination Unified Study in HCC-19
HCC - Hepatocellular Carcinoma
RenJi Hospital42 enrolled1 locationNCT06978933
Recruiting
Phase 2
Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
HCC - Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris30 enrolled1 locationNCT06045975
Recruiting
Phase 2
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
RadiotherapyHCC - Hepatocellular Carcinoma
Shanghai Zhongshan Hospital35 enrolled1 locationNCT06870942